The story of copyright's flagship drug presents a interesting case for investors in the drug sector. While initially a blockbuster success, creating vast sums, the exclusivity end and the subsequent entry of off-brand https://pharma759825.madmouseblog.com/22515766/sildenafil-and-the-pharmaceutical-industry-a-speculative-play